Celestial to launch antibiotic for diabetes

Bio-pharmaceutical company Celestial Biolabs is set to launch an antibiotic product for the treatment of diabetes.

New Delhi: Bio-pharmaceutical company Celestial Biolabs is set to launch an antibiotic product for the treatment of diabetes.

"The company is in the process of this natural sea based 100 per cent vegetarian product tenatatively by April 2015," Celestial Biolabs said in a filing to the BSE.

Earlier in 2013, the Hyderabad-based company launched its patented arthiritis management product, Cadalmin Gae.

Celestial Biolabs is currently engaged in the business of manufacturing and sale of bio-pharmaceutical products.

Shares of the company today closed at Rs 47.40 on the BSE, up 5.22 per cent from previous close.

By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link

Close